Product category:
Culture media
News Release from: GE Healthcare | Subject: Ficoll-Paque Premium
Edited by the Laboratorytalk Editorial
Team on 25 October 2005
Sterile media for mononuclear cell
preparation
Ficoll-Paque Premium provides the same proven results as Ficoll-Paquep Plus with the added value of sterile manufacturing standards and ISO quality systems
GE Healthcare has announced the launch of Ficoll-Paque Premium Ficoll-Paque has been used for around 30 years to prepare human mononuclear cells from blood and marrow
This article was originally published on Laboratorytalk on 18 Apr 2003 at 8.00am (UK)
Related stories
Tips to improve radiochemical safety
Contains reaction-sized aliquots of radionucleotide in a solution-free format, making experiments easier and safer to do
20,000 human genes in a single experiment
Bioarray can be used to identify up or down regulated genes involved in key biological processes including oncogenesis, metabolism, inflammation and apoptosis
Ficoll-Paque Premium provides the same proven results as Ficoll-Paque Plus with the added value of sterile manufacturing standards and ISO quality systems.
"Compliance to GMP and quality standards is increasingly important to our customers using reagents such as Ficoll-Paque.
"The new Ficoll-Paque Premium provides our customers with the proven attributes of Ficoll-Paque Plus, but with the added assurance of stringent manufacturing process controls and adherence to quality systems to reduce risk", said Nigel Darby, VP of research and development, protein separations at GE Healthcare.
"We're proud to offer this latest value product to our cell processing platform".
Ficoll-Paque Premium is based on Ficoll-Paque Plus, which has a proven track record as a sterile density medium for the isolation of high yields of mononuclear cells from bone marrow, peripheral blood, and umbilical cord blood.
Ficoll-Paque Premium differs from Ficoll-Paque Plus in that it is manufactured in a strictly controlled environment compliant with ISO and EC Guide to GMP (good manufacturing practice), annex 1, Manufacture of Sterile Medicinal Products, and in accordance with the recommendations of the United States Pharmacopeia (section 1043) for the manufacture of cell therapy products.
ISO and GMP compliance requires stringency in validation and documentation of manufacturing procedures, and adherence to strict quality systems.
This secures the high product quality and safety of Ficoll-Paque Premium, with product sterility, low endotoxin levels, and reproducible performance.
All other aspects of the Ficoll Paque Premium are the same as for Ficoll-Paque Plus.
• GE Healthcare: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
